Beyond Wall Thickness: Multimodality Imaging for Differentiating HCM, HFpEF, and Cardiac Amyloidosis to Optimize Patient-Centered Care
December 04, 2026
Milan
Long-Term Cardiovascular Risk Reduction With Evolocumab: Insights From FOURIER-OLE at AHA 2026
Marc S. Sabatine, MD, MPH
Key Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis
Ranya N. Sweis, MD, MS, FACC, FSCAI
Unmasking HCM in Patients With Preserved EF: Diagnostic Clarity, Evolving Evidence, and Emerging Therapeutic Strategies
Ahmad Masri, MD, MS
Robert J. Chilton, DO, FACC, FACP, FACOI, FAHA
Christopher M. Bell, ACNP
SONATA-HCM: What’s on the Horizon?
Non-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
Michelle Michels, MD, PhD
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
Ellie Kelepouris, MD, FACP, FAHA
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Pauline A. Swift, PhD
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
Potassium Binders to Optimize GDMT Therapy in HFrEF
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Treating Methamphetamine-Associated PAH: The Missing Piece in Patient Care
John Kingrey, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.